A7RC
A7RC is a multifunctional peptide used in tumor-targeted therapy, with Cysteine added to the C-terminal of the A7R peptide (sequence: ATWLPPR). A7R is a ligand of the NRP-1 receptor, regulating intracellular signal transduction related to tumor vascularization and tumor growth[1].
Product Specifications
CAS Number
632358-46-4
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
O=C(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC(C)C)C(N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CS)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N
Molecular Formula
C43H66N12O10S
Molecular Weight
943.12
References & Citations
[1]Cao J, et al. A7RC peptide modified paclitaxel liposomes dually target breast cancer. Biomater Sci. 2015 Dec;3 (12) :1545-54.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
132802-AP 100 µL
RPP40 (Ribonuclease P Protein Subunit p40, RNaseP Protein p40, RNase P Subunit 1, RNASEP1) (AP) discontinued
Sign In for Pricing
View Details GTR15270419 1 Vial
Lentiviral mouse Kcnt2 shRNA (UAS) - Lentiviral mouse Kcnt2 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details MBS1219783-01 0.5 mg (E-Coli)
Recombinant Cicer arietinum Photosystem I reaction center subunit IX (psaJ), partial
Sign In for Pricing
View Details